Back to Search
EDWIN DEJESUS MD
MD
Infectious Disease Physician
NPI: 1295734101Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
ME0063956(FL)
Research & Publications (20)
Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients.
PMID 19357529·J Acquir Immune Defic Syndr·2009
4-observational
A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study).
PMID 19358725·AIDS Res Ther·2009
8-other
Safety and efficacy of enfuvirtide in combination with darunavir-ritonavir and an optimized background regimen in treatment-experienced human immunodeficiency virus-infected patients: the below the level of quantification study.
PMID 18809940·Antimicrob Agents Chemother·2008
3-trial
Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT.
PMID 18373851·AIDS Res Ther·2008
8-other
Use of Dronabinol Improves Appetite and Reverses Weight Loss in HIV/AIDS-Infected Patients.
PMID 17538000·J Int Assoc Physicians AIDS Care (Chic)·2007
8-other
Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS-9137 (JTK-303) in treatment-naive and treatment-experienced patients.
PMID 16936557·J Acquir Immune Defic Syndr·2006
3-trial
Interaction between fosamprenavir, with and without ritonavir, and nevirapine in human immunodeficiency virus-infected subjects.
PMID 16940117·Antimicrob Agents Chemother·2006
3-trial
Once-daily versus twice-daily lamivudine, in combination with zidovudine and efavirenz, for the treatment of antiretroviral-naive adults with HIV infection: a randomized equivalence trial.
PMID 15307010·Clin Infect Dis·2004
3-trial
Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults.
PMID 15472858·Clin Infect Dis·2004
3-trial
Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.
PMID 14513421·J Infect Dis·2003
3-trial
Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1.
PMID 19193109·Clin Infect Dis·2009
3-trial
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.
PMID 19647866·Lancet·2009
3-trial
Safety, pharmacokinetics, and antiretroviral activity of multiple doses of ibalizumab (formerly TNX-355), an anti-CD4 monoclonal antibody, in human immunodeficiency virus type 1-infected adults.
PMID 19015347·Antimicrob Agents Chemother·2009
2-rct
Select updates from the 16th CROI: treatment-related cardiovascular risk, pharmacokinetic issues, and interleukin-2 use.
PMID 19388184·AIDS Read·2009
8-other
Antiretroviral therapy update from the 48th ICAAC/46th IDSA annual meeting.
PMID 19209453·AIDS Read·2009
8-other
Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758.
PMID 19320570·AIDS Res Hum Retroviruses·2009
4-observational
Modulation of K65R selection by zidovudine inclusion: analysis of HIV resistance selection in subjects with virologic failure receiving once-daily abacavir/lamivudine/zidovudine and tenofovir DF (study COL40263).
PMID 19563238·AIDS Res Hum Retroviruses·2009
3-trial
Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis.
PMID 17971715·J Acquir Immune Defic Syndr·2008
2-rct
Antiretroviral treatment update from the 17th International AIDS Conference.
PMID 19062402·AIDS Read·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1707 N MILLS AVE
ORLANDO, FL 32803 - Phone
- (407) 647-3960
Quick Facts
- NPI
- 1295734101
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile